KLF9 anticorps (N-Term)
Aperçu rapide pour KLF9 anticorps (N-Term) (ABIN5536339)
Antigène
Voir toutes KLF9 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 29-57, N-Term
-
Purification
- This antibody is purified through a protein A column, followed by peptide affinity purification.
-
Immunogène
- This KLF9 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 29-57 amino acids from the N-terminal region of human KLF9.
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
-
For WB starting dilution is: 1:1000
For IF starting dilution is: 1:10~50 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.33 mg/mL
-
Buffer
- Supplied in PBS with 0.09 % (W/V) sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
-
-
- KLF9 (Kruppel-Like Factor 9 (KLF9))
-
Autre désignation
- KLF9
-
Sujet
- The protein encoded by this gene is a transcription factor that binds to GC box elements located in the promoter. Binding of the encoded protein to a single GC box inhibits mRNA expression while binding to tandemly repeated GC box elements activates transcription.
-
Poids moléculaire
- 27 kDa
-
ID gène
- 687
-
UniProt
- Q13886
-
Pathways
- Intracellular Steroid Hormone Receptor Signaling Pathway
Antigène
-